Copyright
©The Author(s) 2020.
World J Clin Cases. May 26, 2020; 8(10): 1878-1886
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1878
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1878
Table 4 Comparison of serum endogenous hydrogen sulfide and endothelial cell particles before and after treatment between the two groups
Ligliptin treatment group | Gliquidone treatment group | P value | |
Number of cases | 54 | 56 | |
H2S (μmol/L) | |||
Before treatment | 73.39 (9.28) | 75.58 (10.16) | 0.241 |
After treatment | 40.04 (8.82)a | 56.12 (9.90)a | 0.000 |
Endothelial cell granules | |||
Before treatment | 1459.28 (210.22) | 1430.04 (201.78) | 0.458 |
After treatment | 133.40 (34.39)a | 202.32 (50.43)a | 0.000 |
- Citation: Zhang J, Du YL, Zhang H, Sui H, Hou WK. Ligliptin for treatment of type 2 diabetes mellitus with early renal injury: Efficacy and impact on endogenous hydrogen sulfide and endothelial function. World J Clin Cases 2020; 8(10): 1878-1886
- URL: https://www.wjgnet.com/2307-8960/full/v8/i10/1878.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i10.1878